80 related articles for article (PubMed ID: 8569039)
1. [The clinical study on secretory leukoprotease inhibitor (SLPI) in sera of patients with various pulmonary diseases].
Sugimoto H; Hashimoto N; Ameshima S; Gejyo F; Ishizaki T; Miyabo S
Rinsho Byori; 1995 Dec; 43(12):1267-72. PubMed ID: 8569039
[TBL] [Abstract][Full Text] [Related]
2. Increased serum concentrations of secretory leukoprotease inhibitor in patients with primary Sjögren's syndrome.
Maruyama M; Sugiyama E; Hori T; Murayama R; Nakazaki S; Yamashita N; Kobayashi M
In Vivo; 1998; 12(5):535-8. PubMed ID: 9827363
[TBL] [Abstract][Full Text] [Related]
3. Relationship between secretory leukocyte protease inhibitor levels in bronchoalveolar lavage fluid and postoperative pulmonary complications in patients with esophageal cancer.
Tsukada K; Miyazaki T; Katoh H; Masuda N; Ojima H; Fukuchi M; Manda R; Fukai Y; Nakajima M; Sohda M; Kuwano H
Am J Surg; 2005 Apr; 189(4):441-5. PubMed ID: 15820457
[TBL] [Abstract][Full Text] [Related]
4. Serum secretory leukoprotease inhibitor levels to diagnose pneumonia in the elderly.
Kida K; Mizuuchi T; Takeyama K; Hiratsuka T; Jinno S; Hosoda K; Imaizumi A; Suzuki Y
Am Rev Respir Dis; 1992 Dec; 146(6):1426-9. PubMed ID: 1360778
[TBL] [Abstract][Full Text] [Related]
5. Analysis of secretory leukocyte protease inhibitor (SLPI) in bronchial secretions from patients with hypersecretory respiratory diseases.
Kouchi I; Yasuoka S; Ueda Y; Ogura T
Tokushima J Exp Med; 1993 Jun; 40(1-2):95-107. PubMed ID: 8105562
[TBL] [Abstract][Full Text] [Related]
6. Serum and bronchial lavage fluid concentrations of IL-8, SLPI, sCD14 and sICAM-1 in patients with COPD and asthma.
Hollander C; Sitkauskiene B; Sakalauskas R; Westin U; Janciauskiene SM
Respir Med; 2007 Sep; 101(9):1947-53. PubMed ID: 17574828
[TBL] [Abstract][Full Text] [Related]
7. Secreted leukocyte protease inhibitor is present in aqueous humours from cataracts and other eye pathologies.
Janciauskiene S; Brandt L; Wallmark A; Westin U; Krakau T
Exp Eye Res; 2006 Mar; 82(3):505-11. PubMed ID: 16202405
[TBL] [Abstract][Full Text] [Related]
8. The secretory leukoprotease inhibitor (SLPI) promoter for ovarian cancer gene therapy.
Barker SD; Coolidge CJ; Kanerva A; Hakkarainen T; Yamamoto M; Liu B; Rivera AA; Bhoola SM; Barnes MN; Alvarez RD; Curiel DT; Hemminki A
J Gene Med; 2003 Apr; 5(4):300-10. PubMed ID: 12692864
[TBL] [Abstract][Full Text] [Related]
9. Regulatory effects of endogenous protease inhibitors in acute lung inflammatory injury.
Gipson TS; Bless NM; Shanley TP; Crouch LD; Bleavins MR; Younkin EM; Sarma V; Gibbs DF; Tefera W; McConnell PC; Mueller WT; Johnson KJ; Ward PA
J Immunol; 1999 Mar; 162(6):3653-62. PubMed ID: 10092827
[TBL] [Abstract][Full Text] [Related]
10. Use of serum secretory leukocyte protease inhibitor levels in patients to improve specificity of ovarian cancer diagnosis.
Tsukishiro S; Suzumori N; Nishikawa H; Arakawa A; Suzumori K
Gynecol Oncol; 2005 Feb; 96(2):516-9. PubMed ID: 15661245
[TBL] [Abstract][Full Text] [Related]
11. Salivary secretory leukocyte protease inhibitor increases in HIV infection.
Lin AL; Johnson DA; Stephan KT; Yeh CK
J Oral Pathol Med; 2004 Aug; 33(7):410-6. PubMed ID: 15250833
[TBL] [Abstract][Full Text] [Related]
12. Increased secretory leukoprotease inhibitor in patients with nonsmall cell lung carcinoma.
Ameshima S; Ishizaki T; Demura Y; Imamura Y; Miyamori I; Mitsuhashi H
Cancer; 2000 Oct; 89(7):1448-56. PubMed ID: 11013357
[TBL] [Abstract][Full Text] [Related]
13. [Effects of secretory leukocyte protease inhibitor on the production of some cytokines and nitric oxide by murine peritoneal macrophages in response to lipopolysaccharide stimulation and M. avium complex infection].
Sano C; Shimizu T; Sato K; Ogasawara K; Tomioka H
Kekkaku; 1999 Jul; 74(7):563-70. PubMed ID: 10481411
[TBL] [Abstract][Full Text] [Related]
14. Cleaved secretory leucocyte protease inhibitor as a biomarker of chymase activity in allergic airway disease.
Belkowski SM; Boot JD; Mascelli MA; Diamant Z; de Garavilla L; Hertzog B; Polkovitch D; Towers M; Batheja A; D'Andrea MR
Clin Exp Allergy; 2009 Aug; 39(8):1179-86. PubMed ID: 19400896
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori infection, but not low-dose aspirin, results in a local reduction of the secretory leukocyte protease inhibitor in gastroduodenal mucosa.
Wex T; Ye S; Treiber G; Vieth M; Roessner A; Malfertheiner P
Helicobacter; 2006 Feb; 11(1):31-8. PubMed ID: 16423087
[TBL] [Abstract][Full Text] [Related]
16. Secretory leukocyte protease inhibitor prevents allergen-induced pulmonary responses in animal models of asthma.
Wright CD; Havill AM; Middleton SC; Kashem MA; Lee PA; Dripps DJ; O'Riordan TG; Bevilacqua MP; Abraham WM
J Pharmacol Exp Ther; 1999 May; 289(2):1007-14. PubMed ID: 10215681
[TBL] [Abstract][Full Text] [Related]
17. Potency of truncated secretory leukoprotease inhibitor assessed in acute lung injury models in hamsters.
Mitsuhashi H; Asano S; Nonaka T; Masuda K; Kiyoki M
J Pharmacol Exp Ther; 1997 Aug; 282(2):1005-10. PubMed ID: 9262369
[TBL] [Abstract][Full Text] [Related]
18. Secretory leukocyte protease inhibitor levels in cervicovaginal secretion of elderly women.
Shimoya K; Zhang Q; Temma K; Kimura T; Tsujie T; Tsutsui T; Wasada K; Kanzaki T; Koyama M; Murata Y
Maturitas; 2006 May; 54(2):141-8. PubMed ID: 16289563
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori-induced downregulation of the secretory leukocyte protease inhibitor (SLPI) in gastric epithelial cell lines and its functional relevance for H. pylori-mediated diseases.
Wex T; Treiber G; Venerito M; Leodolter A; Peitz U; Kuester D; Hritz I; Krueger S; Roessner A; Malfertheiner P
Biol Chem; 2006 Jul; 387(7):893-901. PubMed ID: 16913839
[TBL] [Abstract][Full Text] [Related]
20. Relationship between antimicrobial proteins and airway inflammation and infection in cystic fibrosis.
Sagel SD; Sontag MK; Accurso FJ
Pediatr Pulmonol; 2009 Apr; 44(4):402-9. PubMed ID: 19283840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
